Gullo’s syndrome – what do we know?

Anna Rycyk; Paulina Furtak; Agnieszka Mądro; Beata Kasztelan-Szczerbińska; Halina Cichoż-Lach

doi:10.5114/pg.2020.101133

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2021
vol. 16

Send email

Copy url:

abstract:

Review paper

Gullo’s syndrome – what do we know?

Anna Rycyk

¹

,

Paulina Furtak

²

,

Agnieszka Mądro

¹

,

Beata Kasztelan-Szczerbińska

¹

,

Halina Cichoż-Lach

¹

Department of Gastroenterology with Endoscopy Unit, Medical University, Lublin, Poland
Public, Academic Hospital No. 4, Lublin, Poland

Gastroenterology Rev 2021; 16 (3): 181–183

DOI: https://doi.org/10.5114/pg.2020.101133

Online publish date: 2020/11/22

View full text Get citation

PlumX metrics:

Benign pancreatic hyperenzymemia (Gullo’s syndrome) is characterized by a more than threefold increase of the serum pancreatic enzymes lipase and amylase activity in the absence of any pancreatic disease. Recently, there is an increase in describing cases of Gullo’s syndrome in medical literature. Gullo’s syndrome is a diagnosis of exclusion, and clinicians should be aware of various other conditions which can cause elevation of pancreatic enzymes. However, the diagnostic pathway should be done with the right accuracy to avoid unnecessary examinations.

keywords:

Gullo’s syndrome – what do we know?

Anna Rycyk 1 , Paulina Furtak 2 , Agnieszka Mądro 1 , Beata Kasztelan-Szczerbińska 1 , Halina Cichoż-Lach 1

Gullo's syndrome, benign pancreatic hyperenzymemia

Anna Rycyk

¹

,

Paulina Furtak

²

,

Agnieszka Mądro

¹

,

Beata Kasztelan-Szczerbińska

¹

,

Halina Cichoż-Lach

¹